T. Rowe Price Investment Management, Inc. Scholar Rock Holding Corp Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.79 - $9.11 $779,119 - $1.23 Million	134,563 Added 5.47%	2,592,339 $19.5 Million
Q1 2023 May 15, 2023	SELL	$7.36 - $12.72 $35,445 - $61,259	-4,816 Reduced 0.2%	2,457,776 $19.7 Million
Q4 2022 Feb 14, 2023	SELL	$7.02 - $9.76 $23,875 - $33,193	-3,401 Reduced 0.14%	2,462,592 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$5.33 - $11.3 $13.1 Million - $27.9 Million	2,465,993 New	2,465,993 $17.1 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.